期刊文献+

人骨髓间充质干细胞向血管内皮细胞诱导的研究 被引量:1

Differentiation into vascular endothelial cells from bone marrow mesenchymal stemcellsinvitro
原文传递
导出
摘要 目的 研究人骨髓间充质干细胞(HBMCs)的体外培养和向血管内皮细胞的诱导分化.方法 利用密度梯度离心法将HBMCs从人骨髓中分离出来,体外扩增.将第三代的细胞以含VEGF,bFGF的培养基定向诱导,使其向内皮细胞方向分化.利用免疫细胞化学和流式细胞学检测诱导后的细胞表型.结果 原代未经诱导的骨髓干细胞,培养3周后细胞形态呈梭形,诱导后第7天的细胞呈椭圆形或不规则形,第14天细胞大致呈铺路石样改变.免疫细胞化学显示CD31、CD34、vWF因子呈阳性,流式细胞仪测定CD31、vWF因子阳性率分别为87.5%、82.6%,双阳性率为71.2%.结论 骨髓间充质干细胞在内皮细胞生长因子和碱性成纤维细胞因子的诱导下向血管内皮细胞方向分化. Objective To study the culture methods of human bone marrow mesenchymal stem cells(MSCs) and differentiation into vascular endothelial cells in vitro. Methods Bone marrow mesenchymal stem cells were isolated and cultivated by density gradient centrifugation method. Induce the third generation to vascular endothelial cells with vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). Immunophenotypes of cells were detected by flow cytometry techniques and immunocyte chemistry after the transfection. Results After three weeks of primary culture of MSCs, the cell showed on fusiform shape. After 7 days induction, the cell showed on ellipse and irregular shape. After two weeks transfection, the cell exhibited a Cobblestone-like morphology. The cell expressed CD34,CD31,vWF after transfection by immunocyte chemistry. The positive rates of CD31 vWF were 87.5% and 82.6%, and the double positive rate was 71.2%. Conclusions Bone marrow mesenchymal stem cells can differentiate into vascular endothelial cells by treating with vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF).
出处 《中国实用医刊》 2010年第11期4-7,共4页 Chinese Journal of Practical Medicine
基金 河南省教育厅自然科学研究计划项目(20108320017)
关键词 骨髓间充质干细胞 血管内皮生长因子 碱性成纤维细胞生长因子 血管内皮细胞 诱导分化 Bone marrow mesenchymal stem cells Vascular endothelial growth factor Basic fibroblast growth factor Vascular endothelial cells Differentiation
  • 相关文献

同被引文献19

  • 1Jain RK, Au P, Tam J, et al. Engineering vascularized tissue. Nat Bio-technol, 2005, 23(7): 821-823.
  • 2Liu X,Zhang G, Hou C, et al. Vascularized bone tissue formationinduced by fiber-reinforced scaffolds cultured with osteoblasts and en-dothel ial cells. Biomed Res Int, 2013, 2013: 854917.
  • 3Novosel EC, Kleinhans C,Kluger PJ. Vascularization is the key chal-lenge in tissue engineering. Adv Drug Del iv Rev, 2011, 63(4): 300-311.
  • 4Ohashi K, Yokoyama T, Yamato M, et al. Engineering functional two-and three-dimensional liver systems in vivo using hepatic tissue sheets.Nat Med, 2007,13(7): 880-885.
  • 5Nagamori E, Ngo TX, Takezawa Y, et al. Network formation throughactive migration of human vascular endothelial cells in a multilayeredskeletal myoblast sheet. Biomaterials, 2013,34(3): 662-668.
  • 6Okano T. Current progress of cell sheet tissue engineering and futureperspective. Tissue Eng Part A, 2014, 2014: 24417540.
  • 7Elloumi-Hannachi I,Yamato M, Okano T. Cell sheet engineering: aunique nanotechnology for scaffold-free tissue reconstruction withclinical applications in regenerative medicine. J Intern Med, 2010,267(1):54-70.
  • 8Tsigkou O, Pomerantseva I,Spencer JA, et al. Engineered vascularizedbone grafts. Proc Natl Acad Sci, 2010,107(8): 3311-3316.
  • 9Au P, Tam J, Fukumura D,et al. Bone marrow-derived mesenchymalstem cells facilitate engineering of long-lasting functional vasculature.Blood, 2008, 111(9): 4551-4558.
  • 10Staton CA, Reed MW, Brown NJ. A critical analysis of current in vitroand in vivo angiogenesis assays. Int J Exp Pathol, 2009,90(3): 195-221.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部